These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8193874)

  • 1. Clinical trials. How should they be designed?
    Onken JE; Brazer SR
    Gastrointest Endosc Clin N Am; 1994 Apr; 4(2):423-34. PubMed ID: 8193874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Statistical methods in the evaluation of the therapeutic efficacy--their problems and solutions].
    Tominaga S
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1873-81. PubMed ID: 6764094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allocation of patients to conditions in headache clinical trials: randomization, stratification, and treatment matching.
    Lipchik GL; Nicholson RA; Penzien DB
    Headache; 2005 May; 45(5):419-28. PubMed ID: 15953258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment.
    Licciardone JC; Russo DP
    J Am Osteopath Assoc; 2006 Aug; 106(8):457-63. PubMed ID: 16943515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic approach to clinical trial design and research priority-setting.
    Claxton K; Posnett J
    Health Econ; 1996; 5(6):513-24. PubMed ID: 9003938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of cost effectiveness in technology evaluation.
    Valk PE
    Q J Nucl Med; 2000 Jun; 44(2):197-203. PubMed ID: 10967629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The limits of controlled clinical studies: the case of rheumatology].
    Portioli I
    Ann Ital Med Int; 2000; 15(1):39-46. PubMed ID: 10842890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study design for the evaluation of treatment.
    Morales AJ
    Semin Reprod Endocrinol; 1996 May; 14(2):111-8. PubMed ID: 8796933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness as an outcome in randomized clinical trials.
    Hlatky MA; Owens DK; Sanders GD
    Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating sample size in clinical studies: basic methodological principles.
    Carneiro AV
    Rev Port Cardiol; 2003 Dec; 22(12):1513-21. PubMed ID: 15008067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example.
    Walter SD; Awasthi S; Jeyaseelan L
    Contemp Clin Trials; 2005 Aug; 26(4):459-68. PubMed ID: 16054578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the quality of clinical trials about therapeutic research using the standard of evidence-based medicine].
    Chen F; Zeng YC; Wei HR
    Zhonghua Yan Ke Za Zhi; 2004 Sep; 40(9):609-13. PubMed ID: 15500766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should clinicians interpret clinical trials?
    Califf RM
    Cardiol Clin; 1995 Aug; 13(3):459-68. PubMed ID: 7585780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing the issue of channeling bias in observational studies with propensity scores analysis.
    Lobo FS; Wagner S; Gross CR; Schommer JC
    Res Social Adm Pharm; 2006 Mar; 2(1):143-51. PubMed ID: 17138506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers.
    Glynn RJ; Brookhart MA; Stedman M; Avorn J; Solomon DH
    Med Care; 2007 Oct; 45(10 Supl 2):S38-43. PubMed ID: 17909381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.